Basf Aktiengesellschaft

Karl-Heinz Geiss

Dieter Lenke

Josef Gries

Martin Traut

Klaus Ruebsamen

Hardo Siegel

Manfred Raschack

Achim Moeller

Marco Thyes

Horst Koenig

Claus D Mueller

Hans D Lehmann

Bernhard Schmied

Phillip A Rossy

Harald Weifenbach

Walter-Wielant Wiersdorff

Rolf Kretzschmar

Lothar Daum

Wolfgang Worstmann

Thomas Doerper

Dieter Herr

Jens-Uwe Bliesener

Gerhard Kastner

Hans-Dieter Lehmann

2-alkyl-4-arylmethylaminoquinolines of the general formula I ##STR1## where R.sup.1, R.sup.2, R.sup.5 and R.sup.6 have the meanings specified in the claims, and the physiologically tolerated salts thereof, the use thereof for the preparation of drugs and the drugs thus obtained as described for the inhibition of gastric acid secretion.

2-alkyl-4-arylmethylaminoquinolines, the use thereof and drugs prepared

Polysulfated heparins are used for the preparation of drugs for the prophylaxis and therapy of diseases caused by retroviruses.

Polysulfated heparins for treating diseases caused by retroviruses

2-aryl-3,4-diazabicyclo[4.n.0]-alk-2-en-5-ones of the formula ##STR1## where m, n, R, R.sup.1, R.sup.2 and R.sup.3 have the stated meanings, are used for the treatment of cardiac insufficiency.

2-aryl-3,4-diazabicyclo(4.n.O)alk-2-en-5-ones for the preparation of an

Novel pyrrol-1-ylphenyldihydropyridazinones of the formula ##STR1## their preparation and their use in the treatment of disorders.

Pyrrol-1-ylphenyldihydropyridazinones, their preparation and their use

A process for the preparation of phenylacetonitriles, carrying basic substituents, of the formula I ##STR1## where R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7 and R.sup.8 have the meanings given in the description, by reacting an aldehyde of the formula II ##STR2## with an amine of the formula III ##STR3##

Preparation of phenylacetonitriles carrying basic substituents

Novel carbamates derived from substituted cyclic .beta.-keto-alcohols, their preparation, and pharmaceutical formulations which contain these compounds and which may be used as hypnotics in the treatment of sleep disturbance and as sedatives.

Novel carbamates, their preparation, and pharmaceutical formulations

Compounds of the formula 1 ##STR1## where R.sup.1 is a saturated, unsubstituted or substituted aliphatic radical of 1 to 8 carbon atoms, an unsaturated alkyl radical of 2 to 8 carbon atoms, a cycloalkyl radical of 3 to 7 carbon atoms in the ring or an alkyl radical of 1 to 4 carbon atoms which is substituted by phenyl or by a 5- or 6-membered aromatic heterocyclic ring containing an N, O or S atom, the phenyl ring or the heterocyclic ring itself being unsubstituted, monosubstituted or polysubstituted, and

N-Arylsulfonylpyrroles, their preparation, and therapeutic agents

Growing community of inventors

Beindersheim, Germany

Karl-Heinz Geiss